Eczema: all 1,088 studies

Page 11 of 11. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.

• Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in ChildhoodActive, not recruitingNCT00798226Phase 1
• Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-upCompletedNCT00795496
• Dietetic Effects of Mare's Milk in Patients With Atopic DermatitisCompletedNCT00753805Not applicable
• A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)WithdrawnNCT00746382Phase 2
• Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy DevelopmentCompletedNCT00713089
• Potential Research Study Participant RegistryCompletedNCT00710489
• A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic DermatitisCompletedNCT00703573Phase 2
• A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic DermatitisCompletedNCT00697710Phase 1/2
• Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep PhysiologyCompletedNCT00696397
• Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic DermatitisCompletedNCT00691366
• Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisCompletedNCT00691262Phase 3
• Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic DermatitisCompletedNCT00691145Phase 3
• A Phase 2 Study of PH-10 for the Treatment of Atopic DermatitisCompletedNCT00690807Phase 2
• A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic EczemaCompletedNCT00676884Phase 2
• Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic DermatitisCompletedNCT00673725Phase 4
• Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisCompletedNCT00667160Phase 4
• A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNCT00666302Phase 4
• Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisCompletedNCT00666159Phase 4
• Care of the Dry Skin With Physiogel AI Lotion® (W0156)CompletedNCT00663364Not applicable
• The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis PatientsCompletedNCT00660127
• Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic DermatitisCompletedNCT00616538Phase 4
• Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal RouteCompletedNCT00614731Phase 1
• Novel Topical Treatment of Hand Dermatitis (Eczema)CompletedNCT00614289Phase 1
• Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic DermatitisCompletedNCT00610142Phase 2
• Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic DermatitisTerminatedNCT00583895Phase 2
• A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand EczemaCompletedNCT00576550Phase 4
• Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a MoisturiserCompletedNCT00576238Phase 3
• A Clinical Study in Children and Adolescents With Mild to Moderate Atopic DermatitisCompletedNCT00568412Phase 4
• Long-term Safety of Protopic in Atopic EczemaCompletedNCT00560378Phase 3
• The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic DermatitisCompletedNCT00550472Not applicable
• Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic DermatitisCompletedNCT00533195Phase 3
• Alitretinoin in the Treatment of Chronic Hand EczemaCompletedNCT00519675Phase 3
• Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic DermatitisCompletedNCT00515047
• Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldCompletedNCT00510003Phase 4
• Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand EczemaCompletedNCT00488241Phase 4
• A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic DermatitisCompletedNCT00484003Phase 4
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic DermatitisTerminatedNCT00475605
• Evaluation of Topical B12 for the Treatment of Childhood Atopic DermatitisStatus unknownNCT00465699Not applicable
• Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic DermatitisCompletedNCT00460083Phase 4
• Risk of Asthma in Infants With Atopic DermatitisCompletedNCT00459576
• Prednisolone vs. Ciclosporine in Severe Atopic EczemaCompletedNCT00445081Phase 4
• Dandelion Juice in the Treatment of Dyshidrotic Hand EczemaCompletedNCT00442091Not applicable
• Oral Bacteria and Allergic Disease in ChildrenCompletedNCT00438646
• Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic DermatitisCompletedNCT00438022
• Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic DermatitisCompletedNCT00419406Not applicable
• Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and PsoriasisCompletedNCT00407979
• Immune Response to Varicella Vaccination in Children With Atopic DermatitisCompletedNCT00406081
• LEO19123 Cream in the Treatment of Hand EczemaCompletedNCT00404196Phase 2
• LEO19123 Cream in the Treatment of Atopic DermatitisCompletedNCT00392067Phase 2
• Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)WithdrawnNCT00389103Phase 1
• Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic DermatitisCompletedNCT00379678
• The Effects of Probiotics in Atopic DermatitisWithdrawnNCT00378300Not applicable
• Open-Label,Singel Center Study of Alefacept in Patients With Atopic DermatitisCompletedNCT00376129Phase 2
• Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic DermatitisWithdrawnNCT00368719Phase 4
• Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic DermatitisCompletedNCT00367393Phase 4
• Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 YearsCompletedNCT00365469Phase 2
• Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic DermatitisCompletedNCT00356642Phase 1
• Topical GW842470X In Adults Patients With Moderate Atopic DermatitisCompletedNCT00354510Phase 2
• Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic DermatitisCompletedNCT00351052Phase 3
• Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal PeriodCompletedNCT00325273Phase 3
• Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological ResponsesCompletedNCT00318695Phase 2
• Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic DermatitisCompletedNCT00310492Phase 3
• Histamine Pharmacogenetics in Children With Atopic DermatitisCompletedNCT00277433
• NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®CompletedNCT00275795
• Immunopharmacological Effects of Rituximab in Atopic DermatitisCompletedNCT00267826Not applicable
• Short Term Growth in Children With Atopic DermatitisCompletedNCT00236106Phase 4
• Verification Study of Ciclosporin for Atopic DermatitisCompletedNCT00232076Phase 3
• Long-term Study of Ciclosporin for Atopic DermatitisCompletedNCT00232063Phase 3
• Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic DermatitisCompletedNCT00232011Phase 3
• Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic DermatitisCompletedNCT00231998Phase 3
• Efalizumab for Moderate to Severe Atopic DermatitisCompletedNCT00226057Phase 1
• Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic DermatitisCompletedNCT00224432Not applicable
• Elidel-Study: Elidel in Patients With Atopic DermatitisCompletedNCT00180141Phase 4
• Common Allergens in Skin Tests for Adult Atopic DermatitisStatus unknownNCT00173498
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic DermatitisCompletedNCT00150059Phase 4
• Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic DermatitisCompletedNCT00148746Not applicable
• Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric SubjectsCompletedNCT00139581Phase 4
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic DermatitisCompletedNCT00130364Phase 4
• Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin ConditionsTerminatedNCT00129415Phase 1/2
• Topical NF-kappaB Decoy in the Treatment of Atopic DermatitisCompletedNCT00125333Phase 1/2
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic DermatitisCompletedNCT00121381Phase 4
• Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsCompletedNCT00121316Phase 4
• Quality of Life Study in Adults With Facial EczemaCompletedNCT00120302Phase 4
• Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic DermatitisCompletedNCT00117377Phase 4
• A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisCompletedNCT00106496Phase 4
• Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic DermatitisCompletedNCT00098150
• Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)CompletedNCT00076375Phase 2
• Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy IndividualsCompletedNCT00001760

← Eczema overview